In 2009, Song et al. reported the first case–control study in a Chinese population with breast cancer; results suggest that the miR-502 binding site (rs16917496 T/C polymorphism) of SET8 contributes to an increased breast cancer risk at an early age [23]. Here, KMT5A is linked to breast carcinoma.